Menu UF Health Home Menu

Recent data suggest alternative mechanisms that promote HLA-associated drug syndromes.

Abacavir binds within the antigen-binding cleft of human leukocyte antigen (HLA)-B*57:01. Read more about it here.

Read More
ostrov rock

Molecular Mountaineers

UF drug development researchers are forging new trails to cancer treatments. Read about it here.

Read More

Drug Discovery

We use methods in structure-based drug design to discover and develop novel therapies for human diseases. We are actively targeting cardiovascular diseases, cancer and diabetes by high-throughput virtual screening combined […]

Read More
Prev Next

Contact Us

Please type the characters you see in the image below.

CAPTCHA Image reload captcha

Nature ImmunologySubscribe to this RSS Feed

Inflammatory ILC2 cells: disguising themselves as progenitors?

January 16, 2015

Type 2 cytokine–producing innate lymphoid cells (ILC2 cells) can respond to interleukins IL-25 and IL-33. Distinct subsets are now recognized as inflammatory ILC2 cells and natural ILC2 cells that...

Immunology careers at the NIH, FDA and CDC: different paths that focus on advancing public health

January 16, 2015

The NIH, FDA and CDC offer a wide spectrum of job opportunities focused on improving public health through the discovery and translation of research, the regulation of safe and effective medicines,...

Broad and strong: the ultimate antibody to dengue virus

January 16, 2015

The identification of a new class of cross-reactive monoclonal antibodies that strongly neutralize all four serotypes of dengue virus has important implications for vaccine design as well as for the...

Platelet checkpoint

January 16, 2015